Viewing Study NCT01656720


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-02-25 @ 5:38 AM
Study NCT ID: NCT01656720
Status: COMPLETED
Last Update Posted: 2015-06-09
First Post: 2012-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period
Sponsor: Norgine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Faecal Incontinence View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Faecal Incontinence View
None Suppository View
None Wexner score View